openPR Logo
Press release

Releases New Report on the Lyme Disease Diagnostic Market

02-05-2018 03:42 PM CET | Health & Medicine

Press release from: Transparency Market Research

Releases New Report on the Lyme Disease Diagnostic Market

Lyme disease is an infectious disease caused by bacterial species borrelia. It is a tick borne disease caused by the transmission to humans by the bite of infected ticks. Patients infected with lyme disease suffer from symptoms such as fever, depression, fatigue and skin rashes. If the disease is diagnosed at an early stage then it can be treated with antibiotics. However, if the disease is left untreated then it affects heart, joint and central nervous system and might become a cause for death.

The lyme disease diagnostic market is segmented on the basis of diagnostic tests, emerging diagnostic technologies and end users. Emerging technologies segment comprises of molecular diagnostics, monoclonal antibodies, immunoassays, differential light scattering, liposomes, artificial intelligence, flow cytometry, information technology, diagnostic imaging, gel microdroplets, chromatography and others.

Obtain Report Details @ https://www.transparencymarketresearch.com/lyme-disease-diagnostic.html

The endusers segment of the market includes hospitals, commercial/private labs, public health labs and physicians office. Various forms of laboratory testing for lyme disease are available and among them most widely used are serological test. Among the serological tests most commonly used are ELISA and Western Blot.

Moreover, some laboratories offer tests that include urine antigen tests, lymphocytic transformation test, immunofluorescent staining and PCR tests. New lyme disease diagnostic tests are being developed that are particularly suited for diagnosis of chronic lyme infection using blood sample. These tests overcome the accuracy problems which were encountered in serology based tests.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1658

Globally North America accounts for the largest share of the market owing to the most common tick disease in the U.S. According to the Center for Disease Control and Prevention (CDC) in 2011, 24,364 people were diagnosed with lyme disease in the United States. The European and Asian markets are also expected to emerge in near future owing to increase in patients infected with lyme diseases.

Some of the key players engaged in manufacturing of diagnostic tests include Abbott Laboratories, Affymetrix, Inc., Bio-Rad, Roche Diagnostics among others.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1065<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Releases New Report on the Lyme Disease Diagnostic Market here

News-ID: 931777 • Views: 243

More Releases from Transparency Market Research

Meningitis Diagnostic Testing Market Outlook, Trend, Growth and Share Estimation …
Meningitis Diagnostic Testing Market: Overview The global meningitis diagnostic testing market was valued over US$ 105.5 Mn in 2016 and is projected to register cumulative annual growth rate (CAGR) of over 3.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled "Meningitis Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025". The report suggests that rising demand for innovative
Metformin Hydrochloride API Market to Expand at a CAGR of ~5% from 2021 to 2031
Metformin Hydrochloride API Market: Introduction According to the report, the global metformin hydrochloride API market was valued at ~US$ 300 Mn in 2020 and is projected to expand at a CAGR of ~5% from 2021 to 2031. Metformin hydrochloride is primarily used in the treatment of diabetes. The prevalence of diabetes is expected to increase across the world due to change in lifestyle and factors such as malnutrition and genetic mutations.
Telehealth Market to Reach the Value of US$ 15 Bn by the End of 2028
Telehealth Market: Introduction According to the report, the global telehealth market was valued at US$ 7.8 Bn in 2020 and is projected to expand at a CAGR of 7% from 2021 to 2028. The global telehealth market has witnessed strong growth in the past few years. Telehealth is no longer an option, but a necessity due to the increasing dangers of COVID-19. Read Report Overview - https://www.transparencymarketresearch.com/telehealth-market.html The crisis presents an opportunity
Lyme Disease Treatment Market Growth Trends, Current Demand, and Development Rep …
Lyme Disease Treatment Market: Introduction According to the report, the global Lyme disease treatment market was valued at US$ 1.58 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031. Increase in pet ownership, surge in awareness & adoption of veterinary care, and rise in healthcare expenditure on animals are anticipated to drive the global Lyme disease treatment market from 2021 to 2031.North America

All 5 Releases


More Releases for Lyme

Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs
Lyme Disease Diagnostics Market - Global Industry Insights, Trends, 2026
Lyme disease occurs due to bacterium Borrelia burgdorferi (Bb) and is transmitted to humans through the bite of infected blacklegged ticks. Its general symptoms include fatigue, headache, fever and a skin rash called erythema migrans. The infection can spread to heart, nervous system and joints if left untreated. Centers for Disease Control and Prevention (CDC) recommends a two-step process to diagnose Lyme infection. The first step uses a testing procedure
Global Lyme Disease and Companies Pipeline Review H1 2018
Summary Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches and headache. Risk factors include age, gender and geographic locations. Treatment includes antibiotics. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Lyme Disease - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Lyme Disease (Infectious Disease), complete with analysis by
Lyme Disease Diagnostic Market : Segmentation and Product Research 2019
Lyme disease is an infectious disease caused by bacterial species borrelia. It is a tick borne disease caused by the transmission to humans by the bite of infected ticks. Patients infected with lyme disease suffer from symptoms such as fever, depression, fatigue and skin rashes. If the disease is diagnosed at an early stage then it can be treated with antibiotics. However, if the disease is left untreated then it
Lyme Disease Vaccine Market 2017 - Merck, Merial, Zoetis
Market Reports.biz, recently published a detailed market research study focused on the " Lyme Disease Vaccine Market" across the global, regional and country level. The report provides 360° analysis of " Lyme Disease Vaccine Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Lyme Disease Vaccine industry, and estimates the
As Lyme Disease Cases Expected To Soar In 2017, Global Lyme Diagnostics Introduc …
A recent piece on NBC News With Lester Holt presented some startling facts regarding Lyme Disease. Cases of Lyme Disease are up 500% in Michigan alone. Lyme Disease is spreading across the US and we can expect to see the number of patients infected increase in 2017. As published in the journal Science, Lyme disease carrying ticks are now present in half the counties in the United States. In many